rs35306212

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000465.4(BARD1):​c.1738G>A​(p.Glu580Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000876 in 1,613,984 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E580G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0042 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00053 ( 5 hom. )

Consequence

BARD1
NM_000465.4 missense

Scores

1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:17

Conservation

PhyloP100: 0.662

Publications

9 publications found
Variant links:
Genes affected
BARD1 (HGNC:952): (BRCA1 associated RING domain 1) This gene encodes a protein which interacts with the N-terminal region of BRCA1. In addition to its ability to bind BRCA1 in vivo and in vitro, it shares homology with the 2 most conserved regions of BRCA1: the N-terminal RING motif and the C-terminal BRCT domain. The RING motif is a cysteine-rich sequence found in a variety of proteins that regulate cell growth, including the products of tumor suppressor genes and dominant protooncogenes. This protein also contains 3 tandem ankyrin repeats. The BARD1/BRCA1 interaction is disrupted by tumorigenic amino acid substitutions in BRCA1, implying that the formation of a stable complex between these proteins may be an essential aspect of BRCA1 tumor suppression. This protein may be the target of oncogenic mutations in breast or ovarian cancer. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2013]
BARD1 Gene-Disease associations (from GenCC):
  • BARD1-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • breast cancer
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • hereditary breast carcinoma
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • familial ovarian cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0073722303).
BP6
Variant 2-214745794-C-T is Benign according to our data. Variant chr2-214745794-C-T is described in ClinVar as Benign. ClinVar VariationId is 136499.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00422 (642/152214) while in subpopulation AFR AF = 0.0143 (593/41538). AF 95% confidence interval is 0.0133. There are 2 homozygotes in GnomAd4. There are 291 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 642 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000465.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BARD1
NM_000465.4
MANE Select
c.1738G>Ap.Glu580Lys
missense
Exon 8 of 11NP_000456.2Q99728-1
BARD1
NM_001282543.2
c.1681G>Ap.Glu561Lys
missense
Exon 7 of 10NP_001269472.1Q99728-2
BARD1
NM_001282545.2
c.385G>Ap.Glu129Lys
missense
Exon 4 of 7NP_001269474.1C9IYG1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BARD1
ENST00000260947.9
TSL:1 MANE Select
c.1738G>Ap.Glu580Lys
missense
Exon 8 of 11ENSP00000260947.4Q99728-1
BARD1
ENST00000617164.5
TSL:1
c.1681G>Ap.Glu561Lys
missense
Exon 7 of 10ENSP00000480470.1Q99728-2
BARD1
ENST00000613706.5
TSL:1
c.1330G>Ap.Glu444Lys
missense
Exon 8 of 11ENSP00000484976.2A0A087X2H0

Frequencies

GnomAD3 genomes
AF:
0.00419
AC:
638
AN:
152096
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0142
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00229
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00431
GnomAD2 exomes
AF:
0.00142
AC:
356
AN:
251310
AF XY:
0.00111
show subpopulations
Gnomad AFR exome
AF:
0.0170
Gnomad AMR exome
AF:
0.00159
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000704
Gnomad OTH exome
AF:
0.00245
GnomAD4 exome
AF:
0.000528
AC:
772
AN:
1461770
Hom.:
5
Cov.:
32
AF XY:
0.000454
AC XY:
330
AN XY:
727184
show subpopulations
African (AFR)
AF:
0.0168
AC:
561
AN:
33474
American (AMR)
AF:
0.00177
AC:
79
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39672
South Asian (SAS)
AF:
0.000139
AC:
12
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53416
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000288
AC:
32
AN:
1111948
Other (OTH)
AF:
0.00136
AC:
82
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
49
98
147
196
245
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00422
AC:
642
AN:
152214
Hom.:
2
Cov.:
32
AF XY:
0.00391
AC XY:
291
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.0143
AC:
593
AN:
41538
American (AMR)
AF:
0.00229
AC:
35
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10594
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
68002
Other (OTH)
AF:
0.00427
AC:
9
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
35
70
105
140
175
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00126
Hom.:
3
Bravo
AF:
0.00520
ESP6500AA
AF:
0.0138
AC:
61
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00164
AC:
199
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.000178

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
Familial cancer of breast (6)
-
-
3
Hereditary cancer-predisposing syndrome (3)
-
-
3
not provided (3)
-
-
3
not specified (3)
-
-
1
Breast and/or ovarian cancer (1)
-
-
1
Hereditary breast ovarian cancer syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
20
DANN
Benign
0.97
DEOGEN2
Benign
0.089
T
Eigen
Benign
-0.59
Eigen_PC
Benign
-0.48
FATHMM_MKL
Benign
0.078
N
LIST_S2
Uncertain
0.90
D
MetaRNN
Benign
0.0074
T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
1.1
L
PhyloP100
0.66
PrimateAI
Benign
0.43
T
PROVEAN
Benign
-1.1
N
REVEL
Benign
0.14
Sift
Benign
0.58
T
Sift4G
Benign
0.69
T
Polyphen
0.041
B
Vest4
0.41
MVP
0.83
MPC
0.10
ClinPred
0.0045
T
GERP RS
3.3
Varity_R
0.096
gMVP
0.39
Mutation Taster
=87/13
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35306212; hg19: chr2-215610518; API